Biotech Fund Dumps Million: What It Signals for Investors
A major biotech-focused fund recently exited a large Nuvalent position, sparking questions about fund flows and stock...
Some index funds distribute fewer capital gains than others, which can reduce tax surprises and improve after-tax performance over time.
28,126 articlesA major biotech-focused fund recently exited a large Nuvalent position, sparking questions about fund flows and stock...
Investors chase the next big moonshot, but headlines can blur reality. This guide breaks down how to assess whether s...
Headwinds have pressured Vornado, but two strategic catalysts could unlock meaningful upside. This guide breaks down ...
Nu Holdings already has more customers than many U.S. banks. The bigger question for investors is: how much revenue c...
Bastion Asset Management just revealed a new stake in Parsons, signaling confidence in steady government spending on ...
Gas prices have moved sharply, with a $0.48 jump in one week. This article breaks down the reasons behind the move, w...
A sharp AI-led scare could hammer markets, but it might also open a window to buy quality crypto assets at reduced pr...
Fox Factory's Q4 2025 results shed light on demand for high-performance suspensions and the company’s margin discipli...
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Imagine starting 2026 with $10,000 in intel. By mid-2026, that stake could push past $30,000 as the stock rallied. Th...
Nvidia surged into the spotlight as a long-term wealth engine for many investors. This guide asks the hard question: ...
Anna Duggar’s Instagram comeback signals more than a public return. This in-depth piece breaks down what it means for...